FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283384138> ?p ?o ?g. }

• W4283384138 endingPage "52" @default.
• W4283384138 startingPage "51" @default.
• W4283384138 abstract "Background: The prognostic and biologic significance of circular RNAs (circRNAs) in patients with acute myeloid leukemia (AML) has been reported. Circular PCMTD1 (cPCMTD1) was among the circRNAs that were prognostic in this disease. Aims: To study the functional role of cPCMTD1 in leukemias. Methods: We used RNase H-recruiting, locked nucleic acid-modified oligonucleotides (gapmers) for knock-down (KD) experiments. Cell cycle analyses were performed with bromodeoxyuridine and 7-actinomycin D staining. Chloro-deoxyuridine (CldU) and iodo-deoxyuridine (IdU) were used for DNA fiber assays. Results: To study whether cPCMTD1 is important for leukemia, we KD-cPCMTD1 using gapmers that specifically degraded the circular transcript without affecting the levels of the linear PCMTD1. Among the 8 AML cell lines that were tested, we found that depletion of the cPCMTD1 led to a decrease in the proliferating fraction and potent G2/M blockade of only K-562 and LAMA-84 CML-BC cells. In contrast, linear PCMTD1-KD did not have any effect on cell cycle. Mass cytometry (CyTOF) experiments validated the cell cycle blockade after cPCMTD1-KD and identified an increase of H2AX phosphorylation. We validated this finding with western blots and could also show that cPCMDT1-KD led to an increase in the phosphorylation of the ATM, ATR, CHK1, DNA-PK and RPA32 proteins. Further, DNA fiber assays detected a global decrease in the length of CldU- and IdU-labeled fibers as well as of the IdU/CldU ratio in the cPCMTD1-KD cells compared to controls. These results were confirmed by COMET assays. Taken together these data indicate that cPCMTD1-KD causes impaired DNA replication in CML-BC. Then, we examined whether we found in CML-BC cell lines was also true for patients. Thus, we measured cPCMDT1 expression in a panel of CML patients in chronic phase (n=15), accelerated phase (n=4) and blast crises (n=7) and we found a significant increase of cPCDMT1 in CML-BC with respect to chronic and accelerated phases. Next, we performed cPCMDT1-KD in CML-BC patient samples and found increase of H2AX phosphorylation. Like the cell line data, cPCMDT1-KD in 3 samples from AML patients had no functional effect. Finally, after confirming that cPCMDT1 is most abundant in the cytoplasm, in silico analysis and polysome profiling experiments indicated that cPCMDT1 encodes for a small protein. We generated a custom antibody that detected the predicted protein of 30kD, which was depleted after cPCMDT1-KD. Immunoprecipitation experiments followed by mass spectrometry analysis using our custom antibody showed a strong and specific enrichment of the BTR complex (BLM, TOP3A and RMI1), which is implicated in DNA replication and repair. cPCMDT1-KD had no effect on the total amount of each of the three proteins but reduced their interaction and the amount of the formed BTR complex. To validate the therapeutic potential of this strategy we developed a CML-BC PDX model by transplanting a CML-BC patient sample into NSGS mice. This PDX is very aggressive, and mice die from disease by 20 weeks. We are currently treating these mice in vivo with lipid nanoparticle anti-cPCMDT1 gapmers. Results will be updated in the meeting. Summary/Conclusion:cPCMDT1 is a circRNA with protein-coding potential that is over-expressed in CML-BC. cPCDMT1 is critical for the proliferation of CML-BC through the regulation of DNA replication and may represent a novel target for therapy." @default.
• W4283384138 created "2022-06-25" @default.
• W4283384138 creator A5001040112 @default.
• W4283384138 creator A5014318425 @default.
• W4283384138 creator A5029048585 @default.
• W4283384138 creator A5029817611 @default.
• W4283384138 creator A5030113402 @default.
• W4283384138 creator A5047471617 @default.
• W4283384138 creator A5051666211 @default.
• W4283384138 creator A5054275064 @default.
• W4283384138 date "2022-06-01" @default.
• W4283384138 modified "2023-09-26" @default.
• W4283384138 title "S150: BIOLOGY AND FUNCTION OF CIRCULAR PCMDT1 IN CHRONIC MYELOID LEUKEMIA IN BLAST CRISIS (CML-BC)" @default.
• W4283384138 doi "https://doi.org/10.1097/01.hs9.0000843492.04684.3b" @default.
• W4283384138 hasPublicationYear "2022" @default.
• W4283384138 type Work @default.
• W4283384138 citedByCount "0" @default.
• W4283384138 crossrefType "journal-article" @default.
• W4283384138 hasAuthorship W4283384138A5001040112 @default.
• W4283384138 hasAuthorship W4283384138A5014318425 @default.
• W4283384138 hasAuthorship W4283384138A5029048585 @default.
• W4283384138 hasAuthorship W4283384138A5029817611 @default.
• W4283384138 hasAuthorship W4283384138A5030113402 @default.
• W4283384138 hasAuthorship W4283384138A5047471617 @default.
• W4283384138 hasAuthorship W4283384138A5051666211 @default.
• W4283384138 hasAuthorship W4283384138A5054275064 @default.
• W4283384138 hasBestOaLocation W42833841381 @default.
• W4283384138 hasConcept C129312508 @default.
• W4283384138 hasConcept C1491633281 @default.
• W4283384138 hasConcept C153911025 @default.
• W4283384138 hasConcept C203014093 @default.
• W4283384138 hasConcept C2777111502 @default.
• W4283384138 hasConcept C2778260397 @default.
• W4283384138 hasConcept C2778461978 @default.
• W4283384138 hasConcept C2778729363 @default.
• W4283384138 hasConcept C2779282312 @default.
• W4283384138 hasConcept C29537977 @default.
• W4283384138 hasConcept C502942594 @default.
• W4283384138 hasConcept C552990157 @default.
• W4283384138 hasConcept C553184892 @default.
• W4283384138 hasConcept C55493867 @default.
• W4283384138 hasConcept C62112901 @default.
• W4283384138 hasConcept C86803240 @default.
• W4283384138 hasConceptScore W4283384138C129312508 @default.
• W4283384138 hasConceptScore W4283384138C1491633281 @default.
• W4283384138 hasConceptScore W4283384138C153911025 @default.
• W4283384138 hasConceptScore W4283384138C203014093 @default.
• W4283384138 hasConceptScore W4283384138C2777111502 @default.
• W4283384138 hasConceptScore W4283384138C2778260397 @default.
• W4283384138 hasConceptScore W4283384138C2778461978 @default.
• W4283384138 hasConceptScore W4283384138C2778729363 @default.
• W4283384138 hasConceptScore W4283384138C2779282312 @default.
• W4283384138 hasConceptScore W4283384138C29537977 @default.
• W4283384138 hasConceptScore W4283384138C502942594 @default.
• W4283384138 hasConceptScore W4283384138C552990157 @default.
• W4283384138 hasConceptScore W4283384138C553184892 @default.
• W4283384138 hasConceptScore W4283384138C55493867 @default.
• W4283384138 hasConceptScore W4283384138C62112901 @default.
• W4283384138 hasConceptScore W4283384138C86803240 @default.
• W4283384138 hasLocation W42833841381 @default.
• W4283384138 hasLocation W42833841382 @default.
• W4283384138 hasOpenAccess W4283384138 @default.
• W4283384138 hasPrimaryLocation W42833841381 @default.
• W4283384138 hasRelatedWork W1686076540 @default.
• W4283384138 hasRelatedWork W2036788637 @default.
• W4283384138 hasRelatedWork W2350294409 @default.
• W4283384138 hasRelatedWork W2351474733 @default.
• W4283384138 hasRelatedWork W2363671651 @default.
• W4283384138 hasRelatedWork W2374592133 @default.
• W4283384138 hasRelatedWork W2387175565 @default.
• W4283384138 hasRelatedWork W2387753559 @default.
• W4283384138 hasRelatedWork W2389193565 @default.
• W4283384138 hasRelatedWork W2406519419 @default.
• W4283384138 hasVolume "6" @default.
• W4283384138 isParatext "false" @default.
• W4283384138 isRetracted "false" @default.
• W4283384138 workType "article" @default.